Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-12-009819
Filing Date
2012-06-08
Accepted
2012-06-08 15:57:36
Documents
1
Period of Report
2012-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3289
  Complete submission text file 0001179110-12-009819.txt   4756
Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Oncothyreon Inc. (Issuer) CIK: 0001412067 (see all company filings)

EIN.: 260868560 | State of Incorp.: DE | Fiscal Year End: 0612
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 110 110TH AVENUE NE SUITE 685 BELLEVUE WA 98004
Business Address
Jackson Richard L. (Reporting) CIK: 0001418872 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33882 | Film No.: 12897891